Roivant Sciences stock, traded on Nasdaq, saw UBS lift its position and Goldman Sachs grow its holdings, with transactions disclosed in SEC filings.
7 reports, 2 independent
Updated Oct 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 7
- Developments
- 2
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Roivant Sciences stock, traded on Nasdaq, saw UBS lift its position and Goldman Sachs grow its holdings, with transactions disclosed in SEC filings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Various firms boosted or cut holdings in Roivant Sciences stock.1 source
UBS lifted its position while Goldman Sachs grew holdings in Roivant Sciences shares.1 source
Keep exploring
The entities involved
-
Roivant Sciences (United States)
company in New York, United States
-
Nasdaq
American fully electronic stock exchange